Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC2028361072;61073;61074 chr2:178590878;178590877;178590876chr2:179455605;179455604;179455603
N2AB1864256149;56150;56151 chr2:178590878;178590877;178590876chr2:179455605;179455604;179455603
N2A1771553368;53369;53370 chr2:178590878;178590877;178590876chr2:179455605;179455604;179455603
N2B1121833877;33878;33879 chr2:178590878;178590877;178590876chr2:179455605;179455604;179455603
Novex-11134334252;34253;34254 chr2:178590878;178590877;178590876chr2:179455605;179455604;179455603
Novex-21141034453;34454;34455 chr2:178590878;178590877;178590876chr2:179455605;179455604;179455603
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: I
  • RefSeq wild type transcript codon: ATT
  • RefSeq wild type template codon: TAA
  • Domain: Fn3-35
  • Domain position: 13
  • Structural Position: 15
  • Q(SASA): 0.2596
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
I/V rs1159161091 None 0.248 N 0.141 0.074 0.337621943819 gnomAD-3.1.2 6.58E-06 None None None None N None 0 0 0 0 0 None 0 0 1.47E-05 0 0
I/V rs1159161091 None 0.248 N 0.141 0.074 0.337621943819 gnomAD-4.0.0 4.96691E-06 None None None None N None 0 0 None 0 0 None 0 0 6.79472E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
I/A 0.4842 ambiguous 0.4861 ambiguous -0.925 Destabilizing 0.97 D 0.522 neutral None None None None N
I/C 0.663 likely_pathogenic 0.6496 pathogenic -0.762 Destabilizing 1.0 D 0.507 neutral None None None None N
I/D 0.89 likely_pathogenic 0.8866 pathogenic -0.241 Destabilizing 0.999 D 0.642 neutral None None None None N
I/E 0.7976 likely_pathogenic 0.7778 pathogenic -0.317 Destabilizing 0.999 D 0.637 neutral None None None None N
I/F 0.2845 likely_benign 0.3 benign -0.956 Destabilizing 0.989 D 0.443 neutral D 0.525044989 None None N
I/G 0.8184 likely_pathogenic 0.8124 pathogenic -1.122 Destabilizing 0.999 D 0.619 neutral None None None None N
I/H 0.7332 likely_pathogenic 0.7274 pathogenic -0.522 Destabilizing 1.0 D 0.655 neutral None None None None N
I/K 0.5633 ambiguous 0.5431 ambiguous -0.393 Destabilizing 0.999 D 0.624 neutral None None None None N
I/L 0.1837 likely_benign 0.1776 benign -0.514 Destabilizing 0.031 N 0.132 neutral N 0.48030999 None None N
I/M 0.1433 likely_benign 0.1472 benign -0.409 Destabilizing 0.989 D 0.47 neutral N 0.482412829 None None N
I/N 0.4875 ambiguous 0.4886 ambiguous -0.186 Destabilizing 0.998 D 0.651 neutral N 0.495642012 None None N
I/P 0.9049 likely_pathogenic 0.8967 pathogenic -0.617 Destabilizing 0.999 D 0.649 neutral None None None None N
I/Q 0.6603 likely_pathogenic 0.6414 pathogenic -0.43 Destabilizing 0.999 D 0.648 neutral None None None None N
I/R 0.4866 ambiguous 0.464 ambiguous 0.11 Stabilizing 0.999 D 0.649 neutral None None None None N
I/S 0.4757 ambiguous 0.4719 ambiguous -0.719 Destabilizing 0.994 D 0.514 neutral N 0.507208589 None None N
I/T 0.2509 likely_benign 0.2591 benign -0.68 Destabilizing 0.961 D 0.469 neutral N 0.49143106 None None N
I/V 0.0699 likely_benign 0.0693 benign -0.617 Destabilizing 0.248 N 0.141 neutral N 0.399326189 None None N
I/W 0.8863 likely_pathogenic 0.8843 pathogenic -0.956 Destabilizing 1.0 D 0.702 prob.neutral None None None None N
I/Y 0.6884 likely_pathogenic 0.672 pathogenic -0.672 Destabilizing 0.999 D 0.513 neutral None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.